Stay updated on GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Sign up to get notified when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.

Latest updates to the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history shows a new platform revision entry: v3.6.6 superseding v3.6.5. This indicates a small software update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry, v3.6.5, was added to the study history. The previous revision, v3.6.4, was removed from the history.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision entry v3.6.4 was added to the Study Record Versions, updating the historical record to the latest version. The previous entry v3.6.3 was removed as part of this update.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded revision v3.6.3 to the Record History and removed revision v3.6.2. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now includes an expanded footer with official site links and branding, and the record history section lists past versions and their submission dates.SummaryDifference34%

- Check93 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment is closed. The page now shows a new release version 'Revision: v3.6.0', replacing the previous 'v3.5.5'.SummaryDifference0.4%

Stay in the know with updates to GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GO-Gilteritinib Combo in FLT3-ITD AML Clinical Trial page.